Company · Biotech and pharma · Professional services
Financial public relations and communications for listed companies
Melbourne, VIC
Every investor coverage indicates participated in a round Monsoon Communications raised.
Companies Monsoon Communications acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Monsoon Communications. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Australian pharmaceutical developer Hatchtech appoints Tim Waugh, a former Roche divisional vice president, as chief executive officer to lead development and commercialisation of its head lice treatment DeOvo and establish a United States presence.
Portland Orthopaedics wins US FDA approval for its Beacon Primary Knee, licensed from Signal Medical, and uses an AusIndustry grant to develop a revision knee product.
A 2005 notice that Portland Orthopaedics, a Sydney hip and knee implant maker, planned a $5 million IPO, with a December ASX listing expected and Axis Financial Group brokering the offer.